title: Global human papillomavirus vaccination: can it be cost-effective?
authors.affiliation: Academic Unit of Obstetrics and Gynaecology, School of Cancer and Enabling Sciences, University of Manchester, St Mary's Hospital, UK. emma.crosbie@manchester.ac.uk
authors.forename: E J
authors.initials: EJ
authors.lastname: Crosbie
mesh_terms: D003362:Cost-Benefit Analysis; D016527:Drug Costs; D005260:Female; D005544:Forecasting; D014943:Global Health; D006801:Humans; D007110:Immunity, Active / Q000276:immunology; D008403:Mass Screening / Q000191:economics; D032541:Mass Vaccination / Q000191:economics; D030361:Papillomavirus Infections / Q000191:economics* / Q000276:immunology / Q000517:prevention & control; D053918:Papillomavirus Vaccines / Q000191:economics* / Q000276:immunology; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000517:prevention & control / Q000821:virology
chemical_list: D053918:Papillomavirus Vaccines